DRG Will Exhibit at Medlab Asia Pacific 2016!

Feb 29, 2016Events

We are pleased to announce that the DRG Group will exhibit at MEDLAB Asia Pacific 2016. The show will take place in Singapore at The Sands Expo and Convention Centre, from March 22 – 24, 2016.

In addition to the presentation of several new assays we will offer live demonstrations of our fully automated random access analyzer: DRG:HYBRiD-XL®. DRG is also proud to highlight our newest ELISAs like DHT-optimized and Hepcidin 25 (bioactive) High Sensitive ELISA kit.

To learn more about DRG’s Hepcidin kit or the DRG:HYBRiD-XL®, please visit booth J 37!

Meet us at the DRG booth J37!

MedLab_asia_pacific2016

[starbox]

News and Updates

BioCheck Inc Acquires DRG International Inc

by Oleg Vishnevski | Aug 18, 2021 | News | 0 Comments

Transformative deal significantly increases IVD development, manufacturing and sales channel for novel ELISA and Chemiluminescent immunoassay platforms.

Parasites & Helicobacter Pylori in Egyptian Children | Calprotectin- DRG:HYBRiD-XL

by Oleg Vishnevski | Apr 8, 2021 | News, Products | 0 Comments

Parasites & Helicobacter Pylori in Egyptian Children with or without Diabetes with Gastrointestinal Manifestations & High Calprotectin Level

Cortisol & Adrenal Androgens as Independent Predictors

by Oleg Vishnevski | Jan 28, 2021 | Products | 0 Comments

Cortisol and adrenal androgens as independent predictors of mortality in septic patients. Abstract Background and Objective To determine the prognostic value of cortisol, Dehydroepiandrosterone (DHEA) and Dehydroepiandrosterone-sulfate (DHEAS), together with their...

Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.